Three senior staff members at Marie Curie are to leave the charity as part of a restructure that will result in its top management team reducing from eight to six people.
The charity, which supports people with terminal illnesses and their families, said in a statement today that Belinda Brown, its director of people, planning and performance, Andrew Whitehead, director of finance, and Charlie Hooper, chief information officer, would all leave next month.
A spokesman for the charity declined to say whether the three departing directors would be made redundant or whether they would receive any severance packages.
"This was a review of Marie Curie’s corporate services commissioned and led by the four directors responsible for those functions, and they were fully aware that the outcome could be their own departure," he said.
"The review led to a consolidation of the executive leadership, which they fully support."
He said Whitehead, who has been with Marie Curie for the past 10 years, would be taking up the position of finance director at the St Elizabeth’s Centre in Hertfordshire, which provides education, care and medical support for people with epilepsy and other complex needs.
Brown has been with Marie Curie for two years and Hooper for three.
As part of the changes, Penny Laurence-Parr, the charity’s general counsel and company secretary, will become director of strategy and performance from 1 April.
Jackie Freeman, chief financial officer at the restaurant chain Strada, will join Marie Curie on 2 May in the new role of director of corporate services, which includes finance, IT, HR and volunteering.
Laurence-Parr and Freeman will be joined in the new executive team by four other people, whose job titles remain unchanged.
Marie Curie had an income of £156.2m and expenditure of £165.3m in the year to the end of March 2016. It employs almost 5,000 people, including 2,700 clinical staff.
Jane Collins, chief executive of Marie Curie, said the charity needed to adapt to meet the changing environment in which it operated.
"Following a review of our corporate services, we are consolidating roles and responsibilities on the executive team," she said.
"The three outgoing directors, who have led and fully supported this review, have all made significant contributions to our work and strategic objectives, and we are very sorry to see them go.
"The work we are doing to improve our efficiency and effectiveness is an important step in ensuring we remain a sustainable provider of high-quality care and support for people living with terminal illnesses and their families."